One of the hallmarks of Parkinson’s disease is the abnormal accumulation of the α-synuclein protein that causes neuronal death responsible for motor impairments. Dendrimers are highly branched polymers that decrease α-synuclein accumulation in dopaminergic neurons derived from patient stem cells.
Researchers from IDIBELL and ICO describe that CDK4 and CDK6 inhibitors stop tumor cell proliferation and expand the life expectancy in animal models.
Coinciding with the commemoration of World Breast Cancer Day, the Viladecans Against Cancer Association held the opening ceremony of its new fundraising campaign for research
Curiosity will be the object of study of the scientific experiment “Being a Curious Music-Mind” of IDIBELL with DJ Alicia Carrera, which will take place at the CCCB and Sala Salamandra on October 29 and 30.
IDIBELL and UB researchers, together with Mount Sinai, have described a group of microRNAs that would regulate Wnt/β-catenin signalling pathway-dependent breast cancers.
For the first time, one of the variants identified is unrelated to psychiatric disorders and would contribute through other factors such as smoking, insomnia, or the propensity to risk-taking.
Fluorizoline was known for its pro-apoptotic action on various tumor cells. Now, a study by IDIBELL and the University of Barcelona shows that apart from promoting cell death, this compound inhibits the degradation of mitochondria.
Dr. Mònica Povedano, principal investigator at IDIBELL and head of the Functional Unit for Motor Neuron Disease at the Bellvitge University Hospital, has been awarded the 2020 Neuromuscular Disease Prize (scientific modality), granted by the Spanish Society of Neurology (SEN).
The screening programs of cervical cancers diagnosticated by cervical cytologies have reduced the incidence and mortality of this cancer. However, a retrospective study of IDIBELL and ICO that included 371 women treated at the Hospital de Bellvitge has shown that these tests are not effective for endometrial cancer diagnosis.
MCJ protein silencing emerges as a new therapy to prevent liver failure after ischaemia-reperfusion in models of metabolic syndrome and ageing.
